South Western Sydney Clinical School

Aghajani MJ; Cooper A; McGuire H; Jeffries T; Saab J; Ismail K; de Souza P; Bray V; Fazekas de St Groth B; Niles N, 2019, 'Pembrolizumab for anaplastic thyroid cancer: a case study', Cancer Immunology, Immunotherapy, vol. 68, pp. 1921 - 1934, http://dx.doi.org/10.1007/s00262-019-02416-7

Lim SHS; Ip E; Ng W; Chua W; Asghari R; Roohullah A; Descallar J; Henderson C; Spring K; de Souza P, 2019, 'Health-related quality of life during chemoradiation in locally advanced rectal cancer: Impacts and ethnic disparities', Cancers, vol. 11, http://dx.doi.org/10.3390/cancers11091263

Ding PN; Becker T; Bray V; Chua W; Ma Y; Xu B; Lynch D; de Souza P; Roberts T, 2019, 'Plasma next generation sequencing and droplet digital PCR-based detection of epidermal growth factor receptor (EGFR) mutations in patients with advanced lung cancer treated with subsequent-line osimer', Thoracic Cancer, vol. 10, pp. 1879 - 1884, http://dx.doi.org/10.1111/1759-7714.13154

Nimir M; Ma Y; Jeffreys SA; Opperman T; Young F; Khan T; Ding P; Chua W; Balakrishnar B; Cooper A, 2019, 'Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes.', Cells, vol. 8, http://dx.doi.org/10.3390/cells8070688

Ding PN; Becker TM; Bray VJ; Chua W; Ma YF; Lynch D; Po J; Luk AWS; Caixeiro N; de Souza P, 2019, 'The predictive and prognostic significance of liquid biopsy in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: A prospective study', Lung Cancer, vol. 134, pp. 187 - 193, http://dx.doi.org/10.1016/j.lungcan.2019.06.021

Naher S; Padinharakam S; Balakrishnar B; Chua W; Descallar J; Adams D; de Souza P; Harrison M; Lim S, 2019, 'Patterns of Presentation and Treatment Outcomes of Non–clear-cell Renal Cell Carcinoma and Sarcomatoid Renal Cell Carcinoma Patients in 2 Tertiary Referral Centers in Sydney, Australia', Clinical Genitourinary Cancer, vol. 17, pp. e565 - e569, http://dx.doi.org/10.1016/j.clgc.2019.02.006

Clingan PR; Ackland SP; Brungs D; de Souza P; Aghmesheh M; Garg MB; Ranson RD; Parker S; Jokela R; Ranson M, 2019, 'First-in-human phase I study of infusional and bolus schedules of Deflexifol, a novel 5-fluorouracil and leucovorin formulation, after failure of standard treatment', Asia-Pacific Journal of Clinical Oncology, vol. 15, pp. 151 - 157, http://dx.doi.org/10.1111/ajco.13144

Broom A; Kirby E; Kokanović R; Woodland L; Wyld D; de Souza P; Koh ES; Lwin Z, 2019, 'Individualising difference, negotiating culture: Intersections of culture and care', Health (United Kingdom), http://dx.doi.org/10.1177/1363459319829192

Po JW; Ma Y; Balakrishna B; Brungs D; Azimi F; De Souza P; Becker TM, 2019, 'Immunomagnetic isolation of circulating melanoma cells and detection of PD-L1 status', PLoS ONE, vol. 14, http://dx.doi.org/10.1371/journal.pone.0211866

Bi L; Xie C; Yao M; Thae Hnit SS; Vignarajan S; Wang Y; Wang Q; Xi Z; Xu H; Li Z, 2019, 'The histone chaperone complex FACT promotes proliferative switch of G0 cancer cells', International Journal of Cancer, vol. 145, pp. 164 - 178, http://dx.doi.org/10.1002/ijc.32065

Basch EM; Scholz M; de Bono JS; Vogelzang N; de Souza P; Marx G; Vaishampayan U; George S; Schwarz JK; Antonarakis ES, 2019, 'Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint', European Urology, vol. 75, pp. 929 - 937, http://dx.doi.org/10.1016/j.eururo.2018.11.033

Razdan A; de Souza P; Roberts TL, 2018, 'Role of microRNAs in treatment response in prostate cancer', Current Cancer Drug Targets, vol. 18, pp. 929 - 944, http://dx.doi.org/10.2174/1568009618666180315160125

Roohullah A; Cooper A; Lomax AJ; Aung J; Barge A; Chow L; McHale M; Desai J; Whittle JR; Tran B, 2018, 'A phase I trial to determine safety and pharmacokinetics of ASLAN002, an oral MET superfamily kinase inhibitor, in patients with advanced or metastatic solid cancers', Investigational New Drugs, vol. 36, pp. 886 - 894, http://dx.doi.org/10.1007/s10637-018-0588-7

Ho V; Chung L; Singh A; Lea V; Abubakar A; Lim SH; Ng W; Lee M; de Souza P; Shin JS, 2018, 'Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis', BMC Cancer, vol. 18, http://dx.doi.org/10.1186/s12885-018-4776-9

Po JW; Roohullah A; Lynch D; DeFazio A; Harrison M; Harnett PR; Kennedy C; de Souza P; Becker TM, 2018, 'Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin', Journal of Circulating Biomarkers, vol. 7, http://dx.doi.org/10.1177/1849454418782617

Brungs D; Aghmesheh M; de Souza P; Carolan M; Clingan P; Rose J; Ranson M, 2018, 'Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer', Clinical Colorectal Cancer, vol. 17, pp. e549 - e555, http://dx.doi.org/10.1016/j.clcc.2018.05.004

Campbell DH; Lund ME; Nocon AL; Cozzi PJ; Frydenberg M; De Souza P; Schiller B; Beebe-Dimmer JL; Ruterbusch JJ; Walsh BJ, 2018, 'Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer', PLoS ONE, vol. 13, http://dx.doi.org/10.1371/journal.pone.0196017

Brungs D; Lynch D; Luk AWS; Minaei E; Ranson M; Aghmesheh M; Vine KL; Carolan M; Jaber M; De Souza P, 2018, 'Cryopreservation for delayed circulating tumor cell isolation is a valid strategy for prognostic association of circulating tumor cells in gastroesophageal cancer', World Journal of Gastroenterology, vol. 24, pp. 810 - 818, http://dx.doi.org/10.3748/wjg.v24.i7.810

Harris BHL; Walsh JL; Neciunaite R; Manders P; Cooper A; De Souza P, 2018, 'Ring a ring o'roses, a patient with Kaposi's? Pazopanib, pazopanib, it might go away. Mediterranean (classic) Kaposi sarcoma responds to the tyrosine kinase inhibitor pazopanib after multiple lines of', Clinical and Experimental Dermatology, vol. 43, pp. 234 - 236, http://dx.doi.org/10.1111/ced.13302

Ho V; Chung L; Singh A; Lea V; Revoltar M; Lim SH; Tut TG; Ng W; Lee M; de Souza P, 2017, 'Early postoperative low expression of RAD50 in rectal cancer patients associates with disease-free survival', Cancers, vol. 9, http://dx.doi.org/10.3390/cancers9120163

Callari M; Wong S; Lu H; Aldrich-Wright J; De Souza P; Stenzel MH, 2017, 'Drug induced self-assembly of triblock copolymers into polymersomes for the synergistic dual-drug delivery of platinum drugs and paclitaxel', Polymer Chemistry, vol. 8, pp. 6289 - 6299, http://dx.doi.org/10.1039/c7py01162h

Del Re M; Fogli S; Derosa L; Massari F; De Souza P; Crucitta S; Bracarda S; Santini D; Danesi R, 2017, 'The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide', Cancer Treatment Reviews, vol. 55, pp. 71 - 82, http://dx.doi.org/10.1016/j.ctrv.2017.03.001

Luk AWS; Ma Y; Ding PN; Young FP; Chua W; Balakrishnar B; Dransfield DT; De Souza P; Becker TM, 2017, 'CTC-mRNA (AR-V7) analysis from blood samples—impact of blood collection tube and storage time', International Journal of Molecular Sciences, vol. 18, http://dx.doi.org/10.3390/ijms18051047

Callari M; De Souza PL; Rawal A; Stenzel MH, 2017, 'The Effect of Drug Loading on Micelle Properties: Solid-State NMR as a Tool to Gain Structural Insight', Angewandte Chemie - International Edition, vol. 56, pp. 8441 - 8445, http://dx.doi.org/10.1002/anie.201701471

Brungs D; Aghmesheh M; de Souza P; Ng W; Chua W; Carolan M; Clingan P; Healey E; Rose J; Tubaro T, 2017, 'Sidedness is prognostic in locoregional colon cancer: An analysis of 9509 Australian patients', BMC Cancer, vol. 17, http://dx.doi.org/10.1186/s12885-017-3255-z

Powles TB; Escudier B; de Souza P; Chowdhury S; Pook D; Harmenberg U; Basappa N; Geynisman D; Merchan J; Redman BG, 2016, 'Efficacy of cabozantinib (cabo) vs everolimus (eve) by metastatic site and tumor burden in patients (pts) with advanced renal cell carcinoma (RCC) in the phase 3 METEOR trial', Annals of Oncology, vol. 27, pp. vi284, http://dx.doi.org/10.1093/annonc/mdw373.41

de Souza P; Chua W; Clarke S; Goldstein D; Lee C, 2016, 'Inflammatory Markers Have a Role in Renal Cell Carcinoma Prognosis', European Urology Focus, vol. 2, pp. 341 - 342, http://dx.doi.org/10.1016/j.euf.2016.04.007

Ho V; Chung L; Revoltar M; Lim SH; Tut TG; Abubakar A; Henderson CJ; Chua W; Ng W; Lee M, 2016, 'MRE11 and ATM expression levels predict rectal cancer survival and their association with radiotherapy response', PLoS ONE, vol. 11, http://dx.doi.org/10.1371/journal.pone.0167675

Toh JWT; de Souza P; Lim SH; Singh P; Chua W; Ng W; Spring KJ, 2016, 'The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy', Clinical Colorectal Cancer, vol. 15, pp. 285 - 291, http://dx.doi.org/10.1016/j.clcc.2016.07.007

Lee CK; Davies L; Gebski VJ; Lord SJ; Di Leo A; Johnston S; Geyer C; Cameron D; Press MF; Ellis C, 2016, 'Serum human epidermal growth factor 2 extracellular domain as a predictive biomarker for lapatinib treatment efficacy in patients with advanced breast cancer', Journal of Clinical Oncology, vol. 34, pp. 936 - 944, http://dx.doi.org/10.1200/JCO.2015.62.4767

Ma Y; Luk A; Young FP; Lynch D; Chua W; Balakrishnar B; de Souza P; Becker TM, 2016, 'Droplet digital PCR based androgen receptor variant 7 (AR-V7) detection from prostate cancer patient blood biopsies', International Journal of Molecular Sciences, vol. 17, http://dx.doi.org/10.3390/ijms17081264

Caixeiro NJ; Byun HL; Descallar J; Levesque JV; De Souza P; Soon Lee C, 2016, 'Health professionals' opinions on supporting a cancer biobank: Identification of barriers to combat biobanking pitfalls', European Journal of Human Genetics, vol. 24, pp. 626 - 632, http://dx.doi.org/10.1038/ejhg.2015.191

Choueiri TK; Figueroa DJ; Fay AP; Signoretti S; Liu Y; Gagnon R; Deen K; Carpenter C; Benson P; Ho TH, 2015, 'Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: Results from COMPARZ, a randomized controlled trial', Clinical Cancer Research, vol. 21, pp. 1071 - 1077, http://dx.doi.org/10.1158/1078-0432.CCR-14-1993

De Souza PL; Lee CS, 2015, 'The Centre for Oncology Education and Research Translation (CONCERT) Biobank', Open Journal of Bioresources, vol. 2, http://dx.doi.org/10.5334/ojb.ai

Lim SH; Chua W; Henderson C; Ng W; Shin JS; Chantrill L; Asghari R; Lee CS; Spring KJ; de Souza P, 2015, 'Predictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancer', Critical Reviews in Oncology/Hematology, vol. 96, pp. 67 - 80, http://dx.doi.org/10.1016/j.critrevonc.2015.05.003

Saad F; Shore N; Van Poppel H; Rathkopf DE; Smith MR; De Bono JS; Logothetis CJ; De Souza P; Fizazi K; Mulders PFA, 2015, 'Impact of bone-targeted therapies in chemotherapy-naïve metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: Post hoc analysis of study COU-AA-302', European Urology, vol. 68, pp. 570 - 577, http://dx.doi.org/10.1016/j.eururo.2015.04.032

Hnit SST; Xie C; Yao M; Holst J; Bensoussan A; De Souza P; Li Z; Dong Q, 2015, 'p27 Kip1 signaling: Transcriptional and post-translational regulation', The International Journal of Biochemistry & Cell Biology, vol. 68, pp. 9 - 14, http://dx.doi.org/10.1016/j.biocel.2015.08.005

Tut TG; Lim SHS; Dissanayake IU; Descallar J; Chua W; Ng W; De Souza P; Shin JS; Lee CS, 2015, 'Upregulated polo-like kinase 1 expression correlates with inferior survival outcomes in rectal cancer', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0129313

Morris MJ; Molina A; Small EJ; De Bono JS; Logothetis CJ; Fizazi K; De Souza P; Kantoff PW; Higano CS; Li J, 2015, 'Radiographic progression-free survival as a response biomarker in metastatic castration-resistant prostate cancer: COU-AA-302 results', Journal of Clinical Oncology, vol. 33, pp. 1356 - 1363, http://dx.doi.org/10.1200/JCO.2014.55.3875

Sengupta S; Grimison P; Hayne D; Williams S; Chambers S; Desouza P; Stockler M; McJannett M; Toner G; Davis ID, 2015, 'The Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group - A new co-operative cancer trials group in genitourinary oncology', BJU International, vol. 115, pp. 856 - 858, http://dx.doi.org/10.1111/bju.12925

Tognela A; Spring KJ; Becker T; Caixeiro NJ; Bray VJ; Yip PY; Chua W; Lim SH; de Souza P, 2015, 'Predictive and prognostic value of circulating tumor cell detection in lung cancer: A clinician's perspective', Critical Reviews in Oncology/Hematology, vol. 93, pp. 90 - 102, http://dx.doi.org/10.1016/j.critrevonc.2014.10.001

Ryan CJ; Smith MR; Fizazi K; Saad F; Mulders PFA; Sternberg CN; Miller K; Logothetis CJ; Shore ND; Small EJ, 2015, 'Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): Final overall survival analysis of a ran', The Lancet Oncology, vol. 16, pp. 152 - 160, http://dx.doi.org/10.1016/S1470-2045(14)71205-7

Lim SH; Spring KJ; De Souza P; Mackenzie S; Bokey L, 2015, 'Circulating tumour cells and circulating nucleic acids as a measure of tumour dissemination in non-metastatic colorectal cancer surgery', European Journal of Surgical Oncology, vol. 41, pp. 309 - 314, http://dx.doi.org/10.1016/j.ejso.2014.12.005

Scarano W; De Souza P; Stenzel MH, 2015, 'Dual-drug delivery of curcumin and platinum drugs in polymeric micelles enhances the synergistic effects: A double act for the treatment of multidrug-resistant cancer', Biomaterials Science, vol. 3, pp. 163 - 174, http://dx.doi.org/10.1039/c4bm00272e

Tse BWC; Jovanovic L; Nelson CC; De Souza P; Power CA; Russell PJ, 2014, 'From Bench to Bedside: Immunotherapy for Prostate Cancer', BioMed Research International, vol. 2014, http://dx.doi.org/10.1155/2014/981434

Lim SHS; Chua W; Cheng C; Descallar J; Ng W; Solomon M; Bokey L; Wong K; Lee MT; De Souza P, 2014, 'Effect of neoadjuvant chemoradiation on tumor-infiltrating/associated lymphocytes in locally advanced rectal cancers', Anticancer Research, vol. 34, pp. 6505 - 6513

Sebaratnam DF; Martin LK; Venugopal SS; Mangos G; Freiman J; de Souza P; Farnsworth A; Cheung K; Scolyer RA; Murrell DF, 2014, 'Diffuse melanosis cutis in the setting of BRAF^V600E metastatic melanoma', International Journal of Dermatology, vol. 53, pp. 1409 - 1411, http://dx.doi.org/10.1111/ijd.12614

Rathkopf DE; Smith MR; De Bono JS; Logothetis CJ; Shore ND; De Souza P; Fizazi K; Mulders PFA; Mainwaring P; Hainsworth JD, 2014, 'Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302)', European Urology, vol. 66, pp. 815 - 825, http://dx.doi.org/10.1016/j.eururo.2014.02.056

Mak G; Chin M; Nahar N; De Souza P, 2014, 'Cutaneous metastasis of prostate carcinoma treated with radiotherapy: A case presentation', BMC Research Notes, vol. 7, http://dx.doi.org/10.1186/1756-0500-7-505

Callari M; Aldrich-Wright JR; De Souza PL; Stenzel MH, 2014, 'Polymers with platinum drugs and other macromolecular metal complexes for cancer treatment', Progress in Polymer Science, vol. 39, pp. 1614 - 1643, http://dx.doi.org/10.1016/j.progpolymsci.2014.05.002

Caixeiro NJ; Kienzle N; Lim SH; Spring KJ; Tognela A; Scott KF; De Souza P; Becker TM, 2014, 'Circulating tumour cells - A bona fide cause of metastatic cancer', Cancer and Metastasis Reviews, vol. 33, pp. 747 - 756, http://dx.doi.org/10.1007/s10555-014-9502-8

Lim SH-S; Becker TM; de Souza P; Spring KJ; Chua W; Ng WL, 2014, 'Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer', Journal of Clinical Pathology, http://dx.doi.org/10.1136/jclinpath-2014-202499

Lim SHS; Ardern-Holmes S; McCowage G; De Souza P, 2014, 'Systemic therapy in neurofibromatosis type 2', Cancer Treatment Reviews, vol. 40, pp. 857 - 861, http://dx.doi.org/10.1016/j.ctrv.2014.05.004

Caixeiro NJ; Kienzle N; Lim SH; Spring KJ; Tognela A; Scott KF; de Souza P; Becker TM, 2014, 'Circulating tumour cells-a bona fide cause of metastatic cancer', Cancer and Metastasis Reviews, http://dx.doi.org/10.1007/s10555-014-9502-8

Lim SH; Delaney GP; Descallar J; Sayaloune P; Papadatos G; de Souza P, 2014, 'Outcomes of ethnic minority groups with node-positive, non-metastatic breast cancer in two tertiary referral centers in Sydney, Australia.', PLoS One, vol. 9, pp. e95852, http://dx.doi.org/10.1371/journal.pone.0095852

Hovey E; De Souza P; Marx G; Parente P; Rapke T; Hill A; Bonaventura A; Michele A; Craft P; Abdi E, 2014, 'Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy', Supportive Care in Cancer, vol. 22, pp. 1233 - 1242, http://dx.doi.org/10.1007/s00520-013-2076-0

Becker TM; Caixeiro NJ; Lim SH; Tognela A; Kienzle N; Scott KF; Spring KJ; De Souza P, 2014, 'New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use', International Journal of Cancer, vol. 134, pp. 2523 - 2533, http://dx.doi.org/10.1002/ijc.28516

Lim SH; Becker TM; Caixeiro NJ; Kienzle N; Tognela A; Lumba S; De Souza P; Spring KJ; Chua W; Ng WL, 2014, 'Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer', Cancer Letters, vol. 346, pp. 24 - 33, http://dx.doi.org/10.1016/j.canlet.2013.12.019

Motzer RJ; Hutson TE; Cella D; Reeves J; Hawkins R; Guo J; Nathan P; Staehler M; Souza P; Merchan JR, 2013, 'Pazopanib versus sunitinib in metastatic renal-cell carcinoma', New England Journal of Medicine, vol. 369, pp. 722 - 731, http://dx.doi.org/10.1056/NEJMoa1303989

Lim S; de Souza P, 2013, 'Imatinib in neurofibromatosis type 2.', BMJ case reports, vol. 2013

Lim S; de Souza P, 2013, 'Imatinib in neurofibromatosis type 2', BMJ case reports, vol. 2013, http://dx.doi.org/10.1136/bcr-2013-010274

Won ACM; Gurney H; Marx G; De Souza P; Patel MI, 2013, 'Primary treatment of the prostate improves local palliation in men who ultimately develop castrate-resistant prostate cancer', BJU INTERNATIONAL, vol. 112, pp. E250 - E255, http://dx.doi.org/10.1111/bju.12169

Ryan CJ; Smith MR; De Bono JS; Molina A; Logothetis CJ; De Souza P; Fizazi K; Mainwaring P; Piulats JM; Ng S, 2013, 'Abiraterone in metastatic prostate cancer without previous chemotherapy', New England Journal of Medicine, vol. 368, pp. 138 - 148, http://dx.doi.org/10.1056/NEJMoa1209096

Paz-Ares L; Bálint B; De Boer RH; Van Meerbeeck JP; Wierzbicki R; De Souza P; Galimi F; Haddad V; Sabin T; Hei YJ, 2013, 'A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer', Journal of Thoracic Oncology, vol. 8, pp. 329 - 337, http://dx.doi.org/10.1097/JTO.0b013e31827ce554

Suttle AB; De Souza P; Arumugham T, 2013, 'Bayesian methods for pharmacokinetic/ pharmacodynamic modeling of pazopanib-induced increases in blood pressure and transaminases', Journal of Clinical Pharmacology, vol. 53, pp. 377 - 384, http://dx.doi.org/10.1002/jcph.16

Fox P; Hudson M; Brown C; Lord S; Gebski V; De Souza P; Lee CK, 2013, 'Markers of systemic inflammation predict survival in patients with advanced renal cell cancer', British Journal of Cancer, vol. 109, pp. 147 - 153, http://dx.doi.org/10.1038/bjc.2013.300

Weber MF; Smith DP; O'Connell DL; Patel MI; de Souza PL; Sitas F; Banks E, 2013, 'Risk factors for erectile dysfunction in a cohort of 108 477. Australian men', Medical Journal of Australia, vol. 199, pp. 107 - 111, http://dx.doi.org/10.5694/mja12.11548

Won ACM; Gurney H; Marx G; De Souza P; Patel MI, 2013, 'Primary treatment of the prostate improves local palliation in men who ultimately develop castrate-resistant prostate cancer', BJU International, vol. 112, http://dx.doi.org/10.1111/bju.12169

Yee GPC; de Souza P; Khachigian LM, 2013, 'Current and potential treatments for cervical cancer', Current Cancer Drug Targets, vol. 13, pp. 205 - 220, http://dx.doi.org/10.2174/1568009611313020009

Scarano W; Duong HTT; Lu H; De Souza PL; Stenzel MH, 2013, 'Folate conjugation to polymeric micelles via boronic acid ester to deliver platinum drugs to ovarian cancer cell lines', Biomacromolecules, vol. 14, pp. 962 - 975, http://dx.doi.org/10.1021/bm400121q

Kim M; Li M; Intong LRA; Tran K; Melbourne W; Marucci D; Bucci J; De Souza P; Mallesara G; Murrell DF, 2013, 'Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma', British Journal of Dermatology, vol. 169, pp. 208 - 210, http://dx.doi.org/10.1111/bjd.12272

Coupe N; Harrison M; Chua W; De Souza P, 2012, 'Biomarkers for tyrosine kinase inhibitors in renal cell cancer', Translational Andrology and Urology, vol. 1, pp. 216 - 222, http://dx.doi.org/10.3978/j.issn.2223-4683.2012.10.01

Hovey EJ; De Souza PL; Marx GM; Parente P; Rapke T; Hill A; Bonaventura A; Michele A; Craft PS; Abdi EA, 2012, 'Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial.', J Clin Oncol, vol. 30, pp. 211, http://www.ncbi.nlm.nih.gov/pubmed/27967925

Huynh VT; Binauld S; De Souza PL; Stenzel MH, 2012, 'Acid degradable cross-linked micelles for the delivery of cisplatin: A comparison with nondegradable cross-linker', Chemistry of Materials, vol. 24, pp. 3197 - 3211, http://dx.doi.org/10.1021/cm301556b

Hovey EJ; De Souza PL; Marx GM; Parente P; Rapke T; Hill A; Bonaventura A; Michele A; Craft PS; Abdi EA, 2012, 'Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial', JOURNAL OF CLINICAL ONCOLOGY, vol. 30, http://dx.doi.org/10.1200/jco.2012.30.5_suppl.211

Thientosapol E; Nelson M; Descallar J; de Souza P, 2012, 'AN EXPLORATORY ANALYSIS OF THE LONGITUDINAL RELATIONSHIPS BETWEEN PROSTATE SPECIFIC ANTIGEN AND THE INFLAMMATORY MARKERS C-REACTIVE PROTEIN AND ERYTHROCYTE SEDIMENTATION RATE', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol. 8, pp. 58 - 58, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000306960100049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lim S; Descallar J; Sayaloune P; Delaney G; Papadatos G; de Souza P, 2012, 'CORRELATION OF GRADE & HORMONE-RECEPTOR STATUS WITH STAGE IN NODE-POSITIVE, NON-METASTATIC BREAST CANCER', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol. 8, pp. 335 - 335, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310544400357&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lim S; Descallar J; Sayaloune P; Delaney G; Papadatos G; de Souza P, 2012, 'TUMOUR:NODE RATIO IN NODE-POSITIVE, NON-METASTATIC BREAST CANCER', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol. 8, pp. 37 - 37, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000306960100006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hovey E; de Souza P; Marx G; Parente P; Rapke T; Hill A; Bonaventura A; Michele A; Kraft P; Lloyd A, 2012, 'PHASE III, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MODAFINIL FOR FATIGUE IN PATIENTS TREATED WITH DOCETAXEL-BASED CHEMOTHERAPY', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol. 8, pp. 44 - 44, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000306960100015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lee CK; Marschner IC; Simes RJ; Voysey M; Egleston B; Hudes G; De Souza P, 2012, 'Increase in cholesterol predicts survival advantage in renal cell carcinoma patients treated with temsirolimus', Clinical Cancer Research, vol. 18, pp. 3188 - 3196, http://dx.doi.org/10.1158/1078-0432.CCR-11-3137

Boyer M; Horwood K; Pavlakis N; De Souza P; Millward M; Stein B; Johnston M; Abell F; Rischin D, 2012, 'Efficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST study', Asia-Pacific Journal of Clinical Oncology, vol. 8, pp. 248 - 254, http://dx.doi.org/10.1111/j.1743-7563.2012.01540.x

Xu CF; Xue Z; Bing N; King KS; Mccann LA; De souza PL; Goodman VL; Spraggs CF; Mooser VE; Pandite LN, 2012, 'Concomitant use of pazopanib and simvastatin increases the risk of transaminase elevations in patients with cancer', Annals of Oncology, vol. 23, pp. 2470 - 2471, http://dx.doi.org/10.1093/annonc/mds249

Goldstein D; Bennett BK; Webber K; Boyle F; De Souza PL; Wilcken NRC; Scott EM; Toppler R; Murie P; O'Malley L, 2012, 'Cancer-related fatigue in women with breast cancer: Outcomes of a 5-year prospective cohort study', Journal of Clinical Oncology, vol. 30, pp. 1805 - 1812, http://dx.doi.org/10.1200/JCO.2011.34.6148

Huynh VT; Quek JY; De Souza PL; Stenzel MH, 2012, 'Block copolymer micelles with pendant bifunctional chelator for platinum drugs: Effect of spacer length on the viability of tumor cells', Biomacromolecules, vol. 13, pp. 1010 - 1023, http://dx.doi.org/10.1021/bm2017299

Cameron BA; Bennett B; Li H; Boyle F; Desouza P; Wilcken N; Friedlander M; Goldstein D; Lloyd AR, 2012, 'Post-cancer fatigue is not associated with immune activation or altered cytokine production', Annals of Oncology, vol. 23, pp. 2890 - 2895, http://dx.doi.org/10.1093/annonc/mds108

Glass SM; Huang L; King K; Ragone LJ; Ball HA; De Souza PL; Wagstaff J; Spraggs CF; Mooser VE; Pandite LN, 2011, 'Genetic evaluation of fatigue in pazopanib-treated patients (pts) with advanced renal cell carcinoma (RCC).', J Clin Oncol, vol. 29, pp. e15072, http://www.ncbi.nlm.nih.gov/pubmed/28020421

Manners S; Galettis P; Souza PD, 2011, 'Conditions causing gemcitabine crystallization', Journal of Oncology Pharmacy Practice, vol. 17, pp. 395 - 399, http://dx.doi.org/10.1177/1078155210385033

Won CM; Gurney H; Marx G; De Souza P; Patel MI, 2011, 'PRIMARY TREATMENT OF THE PROSTATE IMPROVES LOCAL PALLIATION IN MEN WHO ULTIMATELY DEVELOP CASTRATE RESISTANT PROSTATE CANCER.', JOURNAL OF ENDOUROLOGY, vol. 25, pp. A256 - A257, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000296792201146&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Howes JB; de Souza PL; West L; Huang LJ; Howes LG, 2011, 'Pharmacokinetics of phenoxodiol, a novel isoflavone, following intravenous administration to patients with advanced cancer', BMC Clinical Pharmacology, vol. 11, http://dx.doi.org/10.1186/1472-6904-11-1

De Souza P; Saad F, 2011, 'Bone health in prostate cancer', Expert Review of Endocrinology and Metabolism, vol. 6, pp. 317 - 321, http://dx.doi.org/10.1586/eem.11.4

Xu CF; Bing NX; Ball HA; Rajagopalan D; Sternberg CN; Hutson TE; De Souza P; Xue ZG; McCann L; King KS, 2011, 'Pazopanib efficacy in renal cell carcinoma: Evidence for predictive genetic markers in angiogenesis-related and exposure-related genes', Journal of Clinical Oncology, vol. 29, pp. 2557 - 2564, http://dx.doi.org/10.1200/JCO.2010.32.9110

Li S; de Souza P, 2011, 'Ras isoprenylation and pAkt inhibition by zoledronic acid and fluvastatin enhances paclitaxel activity in T24 bladder cancer cells', Cancers, vol. 3, pp. 662 - 674, http://dx.doi.org/10.3390/cancers3010662

Huynh VT; De Souza P; Stenzel MH, 2011, 'Polymeric micelles with pendant dicarboxylato chelating ligands prepared via a michael addition for cis -platinum drug delivery', Macromolecules, vol. 44, pp. 7888 - 7900, http://dx.doi.org/10.1021/ma2016503

Gu W; Gaborieau M; Huynh VT; De Souza PL; Stenzel MH, 2011, 'Functionalization of microspheres with malonates using Michael Addition as a pathway to create a drug delivery system for platinum drugs for the treatment of liver cancer', Polymer, vol. 52, pp. 5993 - 6002, http://dx.doi.org/10.1016/j.polymer.2011.10.054

Webber K; Goldstein D; Bennett BK; Boyle FM; De Souza PL; Wilcken N; Friedlander M; Lloyd AR, 2010, 'Influence of fatigue after breast cancer adjuvant theraphy on health care utilization and percieved needs', JOURNAL OF CLINICAL ONCOLOGY, vol. 28, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.9047

De Souza PL; Mellado B; Pfister C; Rosenthal M; Castellano DE; Weber D; Ferrara S; Shaik N; Tan E; Patterson SA, 2010, 'Randomized phase II trial of patupilone plus prednisone versus docetaxel plus prednisone in patients with chemotherapy-naive, metastatic, castrate-resistant prostate cancer(CRPC)', JOURNAL OF CLINICAL ONCOLOGY, vol. 28, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.4553

Hutson TE; Davis ID; Machiels JPH; De Souza PL; Rottey S; Hong BF; Epstein RJ; Baker KL; McCann L; Crofts T, 2010, 'Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma', Journal of Clinical Oncology, vol. 28, pp. 475 - 480, http://dx.doi.org/10.1200/JCO.2008.21.6994

Yang S; De Souza P; Alemao E; Purvis J, 2010, 'Quality of life in patients with advanced renal cell carcinoma treated with temsirolimus or interferon-α', British Journal of Cancer, vol. 102, pp. 1456 - 1460, http://dx.doi.org/10.1038/sj.bjc.6605647

Hutson TE; Davis ID; MacHiels JP; De Souza PL; Rottey S; Hong BF; Epstein RJ; Baker KL; McCann L; Crofts T, 2010, 'Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma', Journal of Urology, vol. 184, pp. 1303, http://dx.doi.org/10.1016/j.juro.2010.06.075

De Souza PL; North S; Bolger GB; Spiridonidis H; Lim R; Khoo KS; Phillips J; Fujimori M, 2010, 'A phase II trial of weekly i.v. KW-2170 in advanced castrate-resistant prostate cancer', Asia-Pacific Journal of Clinical Oncology, vol. 6, pp. 292 - 297, http://dx.doi.org/10.1111/j.1743-7563.2010.01328.x

De Souza PL; Russell PJ; Kearsley JH; Howes LG, 2010, 'Clinical pharmacology of isoflavones and its relevance for potential prevention of prostate cancer', Nutrition Reviews, vol. 68, pp. 542 - 555, http://dx.doi.org/10.1111/j.1753-4887.2010.00314.x

Scott KF; Sajinovic M; Hein J; Nixdorf S; Galettis P; Liauw W; de Souza P; Dong Q; Graham GG; Russell PJ, 2010, 'Emerging roles for phospholipase A2 enzymes in cancer', Biochimie, vol. 92, pp. 601 - 610, http://dx.doi.org/10.1016/j.biochi.2010.03.019

Duong HTT; Huynh VT; De Souza P; Stenzel MH, 2010, 'Core-cross-linked micelles synthesized by clicking bifunctional Pt(IV) anticancer drugs to isocyanates', Biomacromolecules, vol. 11, pp. 2290 - 2299, http://dx.doi.org/10.1021/bm100396s

McPherson RAC; Galettis PT; De Souza PL, 2009, 'Enhancement of the activity of phenoxodiol by cisplatin in prostate cancer cells', British Journal of Cancer, vol. 100, pp. 649 - 655, http://dx.doi.org/10.1038/sj.bjc.6604920

Crombie C; Burns WI; Karapetis C; Lowenthal RM; Kirsten F; Davidson JA; Abell F; Reece WHH; Iglesias J; de Souza P, 2009, 'Randomized phase II trial of gemcitabine and either day 1 or day 8 carboplatin for advanced non-small-cell lung cancer: Is thrombocytopenia predictable?', Asia-Pacific Journal of Clinical Oncology, vol. 5, pp. 24 - 31, http://dx.doi.org/10.1111/j.1743-7563.2009.01193.x

Simonetti AC; Humberto de Lima Melo J; Eleutério de Souza PR; Bruneska D; Luiz de Lima Filho J, 2009, 'Immunological's host profile for HPV and Chlamydia trachomatis, a cervical cancer cofactor', Microbes and Infection, vol. 11, pp. 435 - 442, http://dx.doi.org/10.1016/j.micinf.2009.01.004

Figlin RA; De Souza P; McDermott D; Dutcher JP; Berkenblit A; Thiele A; Krygowski M; Strahs A; Feingold J; Boni J, 2009, 'Analysis of PTEN and HIF-1α and correlation with efficacy in patients with advanced renal cell carcinoma treated with temsirolimus versus interferon-α', Cancer, vol. 115, pp. 3651 - 3660, http://dx.doi.org/10.1002/cncr.24438

Khasraw M; Pavlakis N; McCowatt S; Underhill C; Begbie S; de Souza P; Boyce A; Parnis F; Lim V; Harvie R, 2009, 'Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer', Annals of Oncology, vol. 21, pp. 1302 - 1307, http://dx.doi.org/10.1093/annonc/mdp524

Goldstein D; Bennett B; Cameron B; Boyle F; DeSouza P; Wilcken N; Friedlander M; Scott E; Hickie I; Lloyd AAM, 2008, 'A prospective cohort study of fatigue after adjuvant therapy for breast cancer: Association with hematologic, endocrine, and immune parameters', JOURNAL OF CLINICAL ONCOLOGY, vol. 26, http://dx.doi.org/10.1200/jco.2008.26.15_suppl.9596

Amaral MB; Buchholz I; Freire-Maia B; Reher P; De Souza PEA; De Marigo HA; Martins CR; Horta MCR, 2008, 'Advanced osteosarcoma of the maxilla: A case report', Medicina Oral, Patologia Oral y Cirugia Bucal, vol. 13

Harnett P; Buck M; Beale P; Goldrick A; Allan S; Fitzharris B; De Souza P; Links M; Kalimi G; Davies T, 2007, 'Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: An Australian and New Zealand Gynaecological Oncology Group study', International Journal of Gynecological Cancer, vol. 17, pp. 359 - 366, http://dx.doi.org/10.1111/j.1525-1438.2007.00763.x

Friedlander M; Buck M; Wyld D; Findlay M; Fitzharris B; De Souza P; Davies T; Kalimi G; Allan S; Perez D, 2007, 'Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer', International Journal of Gynecological Cancer, vol. 17, pp. 350 - 358, http://dx.doi.org/10.1111/j.1525-1438.2007.00795.x

Grimison P; Galettis P; Manners S; Jelinek M; Metharom E; de Souza PL; Liauw W; Links MJ, 2007, 'Randomized crossover study evaluating the effect of gemcitabine infusion dose rate: Evidence of auto-induction of gemcitabine accumulation', Journal of Clinical Oncology, vol. 25, pp. 5704 - 5709, http://dx.doi.org/10.1200/JCO.2007.10.7078

Graham PH; Clark C; Abell F; Browne L; Capp A; Clingan P; De Sousa P; Fox C; Links M, 2006, 'Concurrent end-phase boost high-dose radiation therapy for non-small-cell lung cancer with or without cisplatin chemotherapy', Australasian Radiology, vol. 50, pp. 342 - 348, http://dx.doi.org/10.1111/j.1440-1673.2006.01597.x

Lofêgo Filho JA; Dadalti P; De Souza DC; De Souza PRC; Da Silva MAL; Takiya CM, 2006, 'Skin grafts in cutaneous oncology', Anais Brasileiros de Dermatologia, vol. 81, pp. 465 - 472

De Souza PL; Liauw W; Links M; Pirabhahar S; Kelly G; Howes LG, 2006, 'Phase I and pharmacokinetic study of weekly NV06 (Phenoxodiol™), a novel isoflav-3-ene, in patients with advanced cancer', Cancer Chemotherapy and Pharmacology, vol. 58, pp. 427 - 433, http://dx.doi.org/10.1007/s00280-006-0189-6

Gan HK; Mitchell PL; Galettis P; Davis ID; Cebon J; De Souza P; Links M, 2006, 'A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors', Cancer Chemotherapy and Pharmacology, vol. 58, pp. 157 - 164, http://dx.doi.org/10.1007/s00280-005-0152-y

Rosen LS; Gordon D; Tchekmedyian NS; Yanagihara R; Hirsh V; Krzakowski M; Pawlicki M; De Souza P; Zheng M; Urbanowitz G, 2004, 'Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: A randomized, phase III, double-blind, pl', Cancer, vol. 100, pp. 2613 - 2621, http://dx.doi.org/10.1002/cncr.20308

Souquet PJ; Price A; Jaworski M; Burillon JP; Aubert D; Fernandez O; Lewis C; De Souza P; Bosque L; Rodrigues Pereira J, 2003, 'Erratum: GLOB-1: A prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patients (Annals of On', Annals of Oncology, vol. 14, pp. 347, http://dx.doi.org/10.1093/annonc/mdg083

Rosen LS; Gordon D; Tchekmedyian S; Yanagihara R; Hirsh V; Krzakowski M; Pawlicki M; de Souza P; Zheng M; Urbanowitz G, 2003, 'Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: A phase III, double-blind, randomized trial - The zoledronic acid lung cance', Journal of Clinical Oncology, vol. 21, pp. 3150 - 3157, http://dx.doi.org/10.1200/JCO.2003.04.105

Diamond TH; Winters J; Smith A; De Souza P; Kersley JH; Lynch WJ; Bryant C, 2001, 'The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade: A double blind, randomized, placebo-controlled crossover study', Cancer, vol. 92, pp. 1444 - 1450, http://dx.doi.org/10.1002/1097-0142(20010915)92:6<1444::AID-CNCR1468>3.0.CO;2-M

Diamond TH; Winters J; Smith A; De Souza P; Kersley JH; Lynch WJ; Bryant C, 2001, 'The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade: a double blind, randomized, placebo-controlled crossover study.', Cancer, vol. 92, pp. 1444 - 1450, http://dx.doi.org/10.1002/1097-0142(20010915)92:6<1444::aid-cncr1468>3.0.co;2-m

Liauw W; Links M; Pirabhahar S; Husband A; Kelly G; De Souza PL, 2001, 'Phase I trial of weekly NV-06 (Phenoxodiol (TM)), a novel isoflavonoid, in patients with advanced cancer.', CLINICAL CANCER RESEARCH, vol. 7, pp. 3694S - 3694S, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000172121800205&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cohen RB; Mueller SC; Haden K; De Souza P, 2000, 'Phase I study of weekly vinorelbine in combination with weekly paclitaxel in adult patients with advanced refractory cancer', Cancer Investigation, vol. 18, pp. 422 - 428, http://dx.doi.org/10.3109/07357900009032813

Thomas E; Jones GA; De Souza PL; Wardrop C; Wusteman F, 2000, 'Measuring blood volume with fluorescent-labeled hydroxyethyl starch', Critical Care Medicine, pp. 627 - 631

De Souza PL; Cooper MR; Imondi AR; Myers CE, 1997, '9-Aminocamptothecin: A topoisomerase I inhibitor with preclinical activity in prostate cancer', Clinical Cancer Research, vol. 3, pp. 287 - 294

De Souza PL; Castillo M; Myers CE, 1997, 'Enhancement of paclitaxel activity against hormone-refractory prostate cancer cells in vitro and in vivo by quinacrine', British Journal of Cancer, vol. 75, pp. 1593 - 1600, http://dx.doi.org/10.1038/bjc.1997.272

Stea S; Bachelor T; Cooper M; De Souza P; Koenig K; Bolton WK, 1996, 'Disposition and bioavailability of ceftazidime after intraperitoneal administration in patients receiving continuous ambulatory peritoneal dialysis', Journal of the American Society of Nephrology, vol. 7, pp. 2399 - 2402

De Souza PL; Friedlander ML, 1995, 'Humoral hypercalcemia associated with adenocarcinoma of the rectum: A case report and review of the literature', American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 18, pp. 126 - 129, http://dx.doi.org/10.1097/00000421-199504000-00006

De Souza P; Friedlander M; Wilde C; Kirsten F; Ryan M, 1994, 'Hypersensitivity reactions to etoposide: A report of three cases and review of the literature', American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 17, pp. 387 - 389, http://dx.doi.org/10.1097/00000421-199410000-00005

De Souza P; Smith RD; Hall J; Gurney H; Harnett PR, 1993, 'A cost-utility approach to the use of 5-fluorouracil and levamisole as adjuvant chemotherapy for Dukes' C colonic carcinoma [5]', Medical Journal of Australia, vol. 158, pp. 866

De Souza PL; Friedlander ML, 1992, 'Prognostic factors in ovarian cancer', Hematology/Oncology Clinics of North America, vol. 6, pp. 761 - 781

Friedlander M; De Souza P; Segelov E, 1992, 'Risk factors, epidemiology, screening, and prognostic factors in female genital cancer', Current Opinion in Oncology, vol. 4, pp. 913 - 922, http://dx.doi.org/10.1097/00001622-199210000-00016

Ryan CJ; Smith MR; Fizazi K; Saad F; Sternberg CN; Logothetis C; Small EJ; Carles J; Flaig TW; Taplin M-E, 2015, 'Impact of crossover and baseline prognostic factors on overall survival (OS) with abiraterone acetate (AA) in the COU-AA-302 final analysis.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Orlando, FL, presented at Genitourinary Cancers Symposium, Orlando, FL, 26 - 28 February 2015, http://dx.doi.org/10.1200/jco.2015.33.7_suppl.142

Spring K; Lim S; Descallar J; Ng W; Chua W; de Souza P; Bokey L; MacKenzie S, 2015, 'Circulating tumour cell release in the peri-operative setting during curative colorectal cancer surgery', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, Barcelona, SPAIN, presented at ESMO 17th World Congress on Gastrointestinal Cancer, Barcelona, SPAIN, 01 - 04 July 2015, http://dx.doi.org/10.1093/annonc/mdv233.297

Lim SH-S; Shin J-S; Tut TG; Ng WTW; Chug W; Dissanayake IU; Spring K; Ng W; Bokey L; De Souza P, 2014, 'Polo-like kinase 1 as a biomarker in rectal cancers', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Chicago, IL, 30 May - 03 June 2014, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.e14542

Lim SH; Shin J-S; Tut TG; Ng WTW; Chua W; Dissanayake IU; Spring KJ; Bokey EL; Ng W; de Souza P, 2014, 'POLO-LIKE KINASE 1 AS A BIOMARKER IN RECTAL CANCER', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 60 - 60, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339716500045&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Yu EY; Saad F; Londhe A; Shore ND; Van Poppel H; Rathkopf DE; Smith MR; Logothetis C; De Souza PL; Fizazi K, 2014, 'Association of alkaline phosphatase (ALP) with clinical outcomes in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results from COU-AA-302', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, presented at Genitourinary Cancers Symposium, San Francisco, CA, 30 January - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.27

Lim SH; Delaney GP; Descallar J; Sayaloune P; Papadatos G; Souza P, 2014, 'Outcomes of ethnic minority groups with node-positive, non-metastatic breast cancer in two tertiary referral canters in Sydney, Australia', in PLoS ONE, http://dx.doi.org/10.1371/journal.pone.0095852

Rathkopf DE; Smith MR; De Bono JS; Logothetis C; Shore N; De Souza PL; Fizazi K; Mulders P; Mainwaring PN; Hainsworth JD, 2013, 'Long-term safety and efficacy analysis of abiraterone acetate (AA) plus prednisone (P) in metastatic castration-resistant prostate cancer (mCRPC) without prior chemotherapy (COU-AA-302)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 31 May - 04 June 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419601610&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Yee GPC; De Souza PL; Khachigian LM, 2013, 'Reducing invasion potential of cervical cancer cells via targeted knockdown of c-Jun', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 31 May - 04 June 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419605150&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Rathkopf DE; Smith MR; De Bono JS; Logothetis C; Shore ND; De Souza PL; Fizazi K; Mulders P; Mainwaring PN; Hainsworth JD, 2013, 'Updated interim analysis (IA) of COU-AA-302, a randomized phase III study of abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) without prior chemo', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Orlando, FL, presented at Genitourinary Cancers Symposium of the Conquer-Cancer-Foundation of American-Society-of-Clinical-Oncology (ASCO), Orlando, FL, 14 - 16 February 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000333679600009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hovey E; Lloyd A; de Souza P; Marx G; Parente P; Rapke T; Hill A; Bonaventura A; Michele A; Craft P, 2013, 'Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy', in Supportive Care in Cancer, pp. 1 - 10, http://dx.doi.org/10.1007/s00520-013-2076-0

Ryan CJ; Smith MR; De Bono JS; Molina A; Logothetis C; De Souza PL; Fizazi K; Mainwaring PN; Piulats Rodriguez JM; Ng S, 2012, 'Interim analysis (IA) results of COU-AA-302, a randomized, phase III study of abiraterone acetate (AA) in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 01 - 05 June 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318026200024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ryan CJ; Morris M; Molina A; Piulats JR; De Souza P; Li J; Kheoh T; De Bono JS; Larson S; Griffin T, 2012, 'ASSOCIATION OF RADIOGRAPHIC PROGRESSION-FREE SURVIVAL (RPFS) ADAPTED FROM PROSTATE CANCER WORKING GROUP 2 (PCWG2) CONSENSUS CRITERIA (APCWG2) WITH OVERALL SURVIVAL (OS) IN PATIENTS (PTS) WITH METASTAT', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, Vienna, AUSTRIA, pp. 294 - 295, presented at 37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, AUSTRIA, 28 September - 02 October 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000309409001375&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lim SH; Descallar J; Sayaloune P; Papadatos G; De Souza P; Delaney G, 2012, 'OUTCOMES OF ETHNIC MINORITY GROUPS WITH NODE-POSITIVE, NON-METASTATIC BREAST CANCER IN A TERTIARY REFERRAL CENTRE IN SYDNEY', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, Vienna, AUSTRIA, pp. 100 - 100, presented at 37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, AUSTRIA, 28 September - 02 October 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000309409000256&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ryan CJ; Smith MR; De Bono JS; Molina A; Logothetis C; De Souza PL; Fizazi K; Mainwaring PN; Piulats Rodriguez JM; Ng S, 2012, 'Interim analysis (IA) results of COU-AA-302, a randomized, phase III study of abiraterone acetate in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 01 - 06 June 2012, http://dx.doi.org/10.1200/jco.2012.30.18_suppl.lba4518

Hovey EJ; De Souza PL; Marx GM; Rapke T; Parente P; Hill A; Bonaventura A; Michele A; Craft PS; Abdi EA, 2012, 'Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 01 - 06 June 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009803130&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lemech CR; Fontela A; Arkenau H-T; Chin MTM; Li S; Liauw WS; Thomas D; De Souza PL, 2012, 'Phase I study of everolimus in combination with fluvastatin and zoledronic acid in patients with solid tumours.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 01 - 06 June 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009802330&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Melbourne W; Tran K; Johnson LA; De Souza P; Lynch W, 2012, 'hENT1 expression in human urothelium; evaluating hENT1 prognostic potential for intravesical Gemcitabine treatment outcome in patients with superficial urothelial carcinoma', in BJU International, Urological Society of Australia and New Zealand, Darwin, pp. 109 40-40; 4 SI APR 2012, presented at Urological Society of Australia and New Zealand, Darwin, 01 January 2012

Lim S; Descallar J; Sayaloune P; Delaney GP; Papadatos G; De Souza P, 2012, 'Tumour:node ratio in node-positive, non-metastatic breast cancer', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. 8 37-37; 2 SI AUG 2012, presented at ANZUP Annual Scientific Meeting, 01 January 2012

Kim MH; Li M; Mather-Hillon J; Melbourne W; Tran K; Daniel BS; De Souza P; Mallesara G; Murrell DF, 2011, 'Increased expression of EGFR in squamous cell carcinoma in recessive dystrophic epidermolysis bullosa and response to Cetuximab', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 32 - 32, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000289470400092&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Paz-Ares L; Balint B; de Boer R; van Meerbeeck JP; Wierzbicki R; Desouza PL; Galimi F; Haddad V; Hei Y; Ramlau R, 2010, 'A RANDOMIZED, PHASE 2 STUDY OF PACLITAXEL (P) AND CARBOPLATIN (C) +/- CONATUMUMAB (CON) FOR FIRST-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC)', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, Milan, ITALY, pp. 137 - 137, presented at 35th European-Society-for-Medical-Oncology (ESMO) Congress, Milan, ITALY, 08 - 12 October 2010, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283115900427&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Webber K; Goldstein D; Bennett BK; Boyle F; De Souza PL; Wilken N; Friedlander M; Lloyd AR, 2010, 'Fatigue after adjuvant therapy for breast cancer influences health care utilisation and perceived needs', in Grunberg SM (ed.), Journal of Clinical Oncology, American Society of Clinical Oncology, Virginia USA, pp. 647s, presented at ., 01 - 01 January 2010

Webber K; Goldstein D; Bennett BK; Boyle F; De Souza PL; Wilken N; Friedlander M; Lloyd AR, 2010, 'Late fatigue after adjuvant therapy for early breast cancer is largely unrelated to cancer or its treatment: 5 year follow-up of a prospective cohort study', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia Pty Ltd, Australia, pp. 53 - 60, presented at ., 01 - 01 January 2010

Webber K; Fontela A; Bonner N; Bell J; Bucci J; Lewis C; de Souza P; Graham P; Links M, 2009, 'CRP predicts tolerance of treatment and overall survival with weekly carboplatin-paclitaxel and concomitant irradiation for locally advanced non-small cell lung cancer', in JOURNAL OF THORACIC ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, pp. S864 - S865, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000269496002560&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dutcher JP; De Souza P; McDermott D; Figlin RA; Berkenblit A; Thiele A; Krygowski M; Strahs A; Feingold J; Hudes G, 2009, 'Effect of temsirolimus versus interferon-α on outcome of patients with advanced renal cell carcinoma of different tumor histologies', in Medical Oncology, pp. 202 - 209, http://dx.doi.org/10.1007/s12032-009-9177-0

Metharom E; Galettis P; Manners S; Jelinek M; De Souza PL; Links MJ, 2009, 'Cytidine Deaminase c.79A > C Polymorphism Affected Optimal Dose Delivery of Gemcitabine', in Drug Metabolism Reviews, Marcel Dekker Inc, New York, NY, USA, pp. 231 - 232, presented at Drug Metabolism Reviews, 01 January 2009

Venugopal S; Martin LK; Mangos G; Freiman J; Cheung K; Farnsworth A; DeSouza P; Murrell DF, 2008, 'A study of rare presentations of metastatic melanoma', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, pp. A75 - A76, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259822500004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bennett B; Goldstein D; Friedlander M; Boyle F; De Souza P; Wilken N; Hickie I; Scott E; Lloyd A, 2008, 'A prospective cohort study of fatigue after adjuvant therapy for breast cancer', in PSYCHO-ONCOLOGY, JOHN WILEY & SONS LTD, pp. S36 - S37, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000257874200071&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chin MTM; Links MJ; Szwajcer; De Souza PL, 2007, 'Lessons learnt in evaluating the target of drug action in a phase 1 trial of oral albendazole –a benzimidazole carbamate anti-helminthic- in patients with cancer refractory to conventional treatments.', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Adelaide, Australia, pp. A79 - A79, presented at Clinical Oncological Society of Australia (COSA) Annual Scientific Meeting 2007, Adelaide, Australia, 01 November 2007, http://www3.interscience.wiley.com/cgi-bin/fulltext/118500669/PDFSTART

Lim SH; Spring K; Chua W; Ng W; Descallar J; Ma Y; Becker TM; De Souza P, 2015, 'Circulating Tumor Cells in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation', in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, ELSEVIER SCIENCE INC, San Antonio, TX, Vol. 93, pp. E522 - E523, presented at 57th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San Antonio, TX, 18 - 21 October 2015, http://dx.doi.org/10.1016/j.ijrobp.2015.07.1883

Lim S; Chua W; Ng W; Descallar J; Bokey L; Spring K; De Souza P, 2015, 'Presence of circulating tumour cells and correlation with inflammatory markers in non-metastatic rectal cancer', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, Vienna, AUSTRIA, Vol. 51, pp. S391 - S391, presented at European Cancer Congress, Vienna, AUSTRIA, 01 January 2015, http://dx.doi.org/10.1016/S0959-8049(16)31092-9

Lim S; Ng W; Chua W; Descallar J; Spring K; De Souza P, 2015, 'Quality of life and circulating tumour cells in patients treated with neoadjuvant chemoradiation for rectal cancer - is there a link?', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, Vienna, AUSTRIA, Vol. 51, pp. S224 - S224, presented at European Cancer Congress, Vienna, AUSTRIA, 01 January 2015, http://dx.doi.org/10.1016/S0959-8049(16)30648-7

Lim SH; Ng W; Chua W; Descallar J; Spring K; De Souza P, 2015, 'PSYCHOLOGICAL PARAMETERS AND CIRCULATING TUMOR CELLS IN LOCALLY ADVANCED RECTAL CANCER', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 11, pp. 57 - 57, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000357957300039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Basch EM; Sholz MC; De Bono JS; Vogelzang NJ; De Souza PL; Marx GM; Vaishampayan UN; George S; Schwarz JK; Antonarakis ES, 2015, 'Final analysis COMET-2: Cabozantinib (Cabo) versus mitoxantrone/prednisone (MP) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) with moderate to severe pain who were previous', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Orlando, FL, Vol. 33, presented at Genitourinary Cancers Symposium, Orlando, FL, 26 - 28 February 2015, http://dx.doi.org/10.1200/jco.2015.33.7_suppl.141

De Souza P; Smith MR; Fizazi K; Saad F; Mulders PFA; Sternberg CN; Miller K; Logothetis CJ; Shore N; Small EJ, 2015, 'Final analysis of the randomised, phase 3, COU-AA-302 study of abiraterone acetate (AA) in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (mCRPC)', in BJU INTERNATIONAL, WILEY-BLACKWELL, Adelaide, AUSTRALIA, Vol. 115, pp. 21 - 22, presented at 68th Annual Scientific Meeting of the Urological-Society-of-Australia-and-New Zealand, Adelaide, AUSTRALIA, 11 - 14 April 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000351395100042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1